Profilakticheskaya Meditsina最新文献

英文中文

Analysis of the interaction of nursing staff with participants of the therapeutic and diagnostic process in modern conditions 分析护理人员与参与者在现代条件下的治疗和诊断过程的互动

Profilakticheskaya Meditsina

Pub Date : 2023-01-01 DOI: 10.17116/profmed20232607138

A. Timurzieva, N. Grishina, M. S. Egorov

引用次数: 0

Quality of cancer screening at the medical check-up stages 在体格检查阶段进行癌症筛查的质量

Profilakticheskaya Meditsina

Pub Date : 2023-01-01 DOI: 10.17116/profmed20232609157

L.Yu. Drozdova, E.S. Ivanova, V.A. Egorov, Yu.S. Rakovskaya

引用次数: 0

Resolution of the Advisory Board «Deficiency/Deficit of vitamin B12 in clinical practice» 咨询委员会关于“临床实践中维生素B12缺乏”的决议

Profilakticheskaya Meditsina

Pub Date : 2023-01-01 DOI: 10.17116/profmed202326011109

引用次数: 1

Metabolic syndrome as a risk factor for oncogenesis 代谢综合征是肿瘤发生的危险因素

Profilakticheskaya Meditsina

Pub Date : 2023-01-01 DOI: 10.17116/profmed20232601170

M. Osadchuk, I. Vasilieva, V. Kozlov, O. Mitrokhina

引用次数: 1

Health promotion among young people 在青年人中促进健康

Profilakticheskaya Meditsina

Pub Date : 2023-01-01 DOI: 10.17116/profmed20232601185

O. Kuznetsova, N. Dikopolskaya, G. Bilalova, M. Shaykhelislamova, Yu.G. Mingazova, T. Zefirov

引用次数: 0

Actual issues and prospects of training nurses for the palliative care system 姑息治疗系统护士培训的现实问题与展望

Profilakticheskaya Meditsina

Pub Date : 2023-01-01 DOI: 10.17116/profmed20232602124

A. Masharipova, N. Nurgaliyeva, G. Derbissalina

引用次数: 0

Perspectives of telemedicine technologies in the treatment of overweight and obesity 远程医疗技术在超重和肥胖治疗中的应用前景

Profilakticheskaya Meditsina

Pub Date : 2023-01-01 DOI: 10.17116/profmed2023260217

V. Dadaeva, V. Stolyar, O. Drapkina

引用次数: 1

COVID-19 in tobacco users 烟草使用者感染COVID-19

Profilakticheskaya Meditsina

Pub Date : 2023-01-01 DOI: 10.17116/profmed20232603171

O. Vorobeva, N. V. Tolmacheva, N. Gimaldinova, L. P. Romanova, I. P. Malov, A.A. Yusov, N. V. Alekseeva

Smoking is a significant social problem threatening the population's health, especially during the coronavirus pandemic. Due to the problem's urgency, we present a clinical case of SARS-CoV-2 infection in a patient with 10 years of smoking and concomitant chronic obstructive pulmonary disease (chronic bronchitis and peribronchial pneumosclerosis). Patient L.K., 42 years old, on 13.10.2022, was hospitalized for several hours at the Emergency Hospital of the Ministry of Health of Chuvashia (Cheboksary) with a severe new coronavirus infection. Secondary diagnosis: Chronic obstructive pulmonary disease Case history: for about two to three weeks, the patient noted an increase in body temperature to 37.2-37.4 degreeC and a cough. He has smoked for about 10 years, 1 pack per day. Computed tomography showed signs of bilateral COVID-associated pneumonitis, alveolitis with 85% involvement and consolidation sites, signs of chronic bronchitis, and peribronchial pneumosclerosis. The diagnosis of COVID-19 was confirmed by a polymerase chain reaction in a nasopharyngeal smear. The NEWS2 score was 9. After the treatment started, the patient died. Histological examination showed perivascular sclerosis, peribronchial pneumosclerosis, atrophic changes in the ciliated epithelium, and structural and functional alteration of the bronchial mucosa. In addition, areas of hemorrhage and inflammatory infiltrate in the bronchial wall were found. Coronavirus is known not to cause bronchitis but bronchiolitis. In the presented case, the patient showed signs of transition of bronchitis to the acute stage. Therefore, it can be assumed that the coronavirus acts as a complicating factor. In addition to the described changes, signs of viral interstitial pneumonia, pulmonary edema, and early development of acute respiratory distress syndrome were identified.Copyright © 2023, Media Sphera Publishing Group. All rights reserved.

吸烟是威胁人们健康的一个重大社会问题，特别是在冠状病毒大流行期间。由于问题的紧迫性，我们报告了一例临床病例SARS-CoV-2感染患者，该患者吸烟10年并伴有慢性阻塞性肺疾病(慢性支气管炎和支气管周围肺硬化)。患者l.k.， 42岁，于2022年10月13日在Chuvashia (Cheboksary)卫生部急诊医院因严重的新型冠状病毒感染住院数小时。继发诊断:慢性阻塞性肺病病史:约2 ~ 3周，患者体温升高37.2 ~ 37.4度，咳嗽。他抽了大约10年的烟，每天一包。计算机断层扫描显示双侧新型冠状病毒相关肺炎、肺泡炎(累及及实变部位达85%)、慢性支气管炎和支气管周围肺炎硬化征象。鼻咽涂片聚合酶链反应证实了COVID-19的诊断。NEWS2的得分是9分。治疗开始后，病人死亡。组织学检查显示血管周围硬化，支气管周围肺硬化，纤毛上皮萎缩，支气管黏膜结构和功能改变。支气管壁可见出血及炎性浸润。已知冠状病毒不会引起支气管炎，而是引起细支气管炎。在本病例中，患者表现出支气管炎过渡到急性期的迹象。因此，可以认为冠状病毒是一个复杂因素。除了上述变化外，还发现了病毒性间质性肺炎、肺水肿和急性呼吸窘迫综合征的早期发展迹象。版权所有©Media Sphera出版集团2023版权所有。

{"title":"COVID-19 in tobacco users","authors":"O. Vorobeva, N. V. Tolmacheva, N. Gimaldinova, L. P. Romanova, I. P. Malov, A.A. Yusov, N. V. Alekseeva","doi":"10.17116/profmed20232603171","DOIUrl":"https://doi.org/10.17116/profmed20232603171","url":null,"abstract":"Smoking is a significant social problem threatening the population's health, especially during the coronavirus pandemic. Due to the problem's urgency, we present a clinical case of SARS-CoV-2 infection in a patient with 10 years of smoking and concomitant chronic obstructive pulmonary disease (chronic bronchitis and peribronchial pneumosclerosis). Patient L.K., 42 years old, on 13.10.2022, was hospitalized for several hours at the Emergency Hospital of the Ministry of Health of Chuvashia (Cheboksary) with a severe new coronavirus infection. Secondary diagnosis: Chronic obstructive pulmonary disease Case history: for about two to three weeks, the patient noted an increase in body temperature to 37.2-37.4 degreeC and a cough. He has smoked for about 10 years, 1 pack per day. Computed tomography showed signs of bilateral COVID-associated pneumonitis, alveolitis with 85% involvement and consolidation sites, signs of chronic bronchitis, and peribronchial pneumosclerosis. The diagnosis of COVID-19 was confirmed by a polymerase chain reaction in a nasopharyngeal smear. The NEWS2 score was 9. After the treatment started, the patient died. Histological examination showed perivascular sclerosis, peribronchial pneumosclerosis, atrophic changes in the ciliated epithelium, and structural and functional alteration of the bronchial mucosa. In addition, areas of hemorrhage and inflammatory infiltrate in the bronchial wall were found. Coronavirus is known not to cause bronchitis but bronchiolitis. In the presented case, the patient showed signs of transition of bronchitis to the acute stage. Therefore, it can be assumed that the coronavirus acts as a complicating factor. In addition to the described changes, signs of viral interstitial pneumonia, pulmonary edema, and early development of acute respiratory distress syndrome were identified.Copyright © 2023, Media Sphera Publishing Group. All rights reserved.","PeriodicalId":37659,"journal":{"name":"Profilakticheskaya Meditsina","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67426794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Atherosclerosis of carotid and lower extremity arteries in patients 40—64 years of age with different cardiovascular risk status 40-64岁不同心血管危险状态患者的颈动脉和下肢动脉粥样硬化

Profilakticheskaya Meditsina

Pub Date : 2023-01-01 DOI: 10.17116/profmed20232604134

V. Genkel, A. Kuznetsova, E. Lebedev, A. Salashenko, L. Pykhova, V. Sumerkina, I. Shaposhnik

引用次数: 0

Cardiometabolic and psychocognitive features of the post-COVID period in patients with atrial fibrillation 房颤患者covid后期心脏代谢和心理认知特征

Profilakticheskaya Meditsina

Pub Date : 2023-01-01 DOI: 10.17116/profmed20232604143

A. Starichkova, L. Khidirova, O. Tsygankova, V. Lukinov

The number of people with long-term consequences of COVID-19 is increasing worldwide. The long-term prognosis for patients remains poorly understood. Objective. To study cardiometabolic and psychocognitive features in comorbid elderly patients with atrial fibrillation (AF), de-pending on the presence of post-COVID syndrome (PCS). Material and methods. The observational analytical cohort study included 223 patients with AF and comorbidity (coronary artery disease, hypertension, obesity, type 2 diabetes mellitus) aged 60-74, who were divided into two groups: group 1 included 123 patients without COVID-19 and group 2 included 110 patients with a history of COVID-19 and the presence of PCS. The study evaluated laboratory and instrumental tests, and a general clinical study assessing psychocognitive disorders using the SPMSQ and HADS questionnaires was conducted. Results and discussion. In COVID-19 survivors, compared with patients of group 1, there were more pronounced atherogenic changes in total cholesterol (TC) (p=0.003), low-density lipoprotein cholesterol (p<0.001), and triglycerides (p=0.011). Lower dia-stolic blood pressure was found in COVID-19 survivors (p<0.001). In addition, patients in group 2 had higher median pulse pressure (p<0.001) and heart rate (p<0.001). In group 2 patients, a larger ascending aorta diameter was observed (p<0.001). The anx-iety-depressive syndrome was more common in COVID-19 survivors with comorbidities, and a statistically significant difference was found in clinical anxiety (24%, p=0.041) and subclinical depression (21%, p=0.015). When assessing cognitive function, mod-erate cognitive impairment was detected in 22% (p=0.005) of patients with PCS and severe cognitive impairment in 2% (p=0.007). Conclusion. In comorbid elderly patients with the post-COVID syndrome, a high prevalence of psychocognitive disorders and adverse cardiometabolic changes were observed, supporting the need for long-term monitoring of the general clinical condition and psychocognitive status of COVID-19 survivors.Copyright © 2023, Media Sphera Publishing Group. All rights reserved.

在世界范围内，受COVID-19长期影响的人数正在增加。患者的长期预后仍然知之甚少。目标。研究合并老年房颤(AF)患者的心脏代谢和心理认知特征，这取决于是否存在covid后综合征(PCS)。材料和方法。观察性分析队列研究纳入223例60-74岁房颤合并合并症(冠状动脉疾病、高血压、肥胖、2型糖尿病)患者，分为两组:1组123例无COVID-19患者，2组110例有COVID-19病史并存在PCS的患者。该研究评估了实验室和仪器测试，并进行了一项使用SPMSQ和HADS问卷评估心理认知障碍的一般临床研究。结果和讨论。在COVID-19幸存者中，与1组患者相比，总胆固醇(TC) (p=0.003)、低密度脂蛋白胆固醇(p<0.001)和甘油三酯(p=0.011)的动脉粥样硬化改变更为明显。COVID-19幸存者的舒张压较低(p<0.001)。此外，2组患者的中位脉压(p<0.001)和心率(p<0.001)较高。2组患者升主动脉直径增大(p<0.001)。焦虑抑郁综合征在合并合并症的COVID-19幸存者中更为常见，临床焦虑(24%，p=0.041)和亚临床抑郁(21%，p=0.015)差异有统计学意义。在评估认知功能时，22%的PCS患者存在中度认知障碍(p=0.005)， 2%的PCS患者存在重度认知障碍(p=0.007)。结论。在合并COVID-19后综合征的老年患者中，观察到心理认知障碍和不良心脏代谢变化的高发率，支持对COVID-19幸存者的一般临床状况和心理认知状态进行长期监测的必要性。版权所有©Media Sphera出版集团2023版权所有。

{"title":"Cardiometabolic and psychocognitive features of the post-COVID period in patients with atrial fibrillation","authors":"A. Starichkova, L. Khidirova, O. Tsygankova, V. Lukinov","doi":"10.17116/profmed20232604143","DOIUrl":"https://doi.org/10.17116/profmed20232604143","url":null,"abstract":"The number of people with long-term consequences of COVID-19 is increasing worldwide. The long-term prognosis for patients remains poorly understood. Objective. To study cardiometabolic and psychocognitive features in comorbid elderly patients with atrial fibrillation (AF), de-pending on the presence of post-COVID syndrome (PCS). Material and methods. The observational analytical cohort study included 223 patients with AF and comorbidity (coronary artery disease, hypertension, obesity, type 2 diabetes mellitus) aged 60-74, who were divided into two groups: group 1 included 123 patients without COVID-19 and group 2 included 110 patients with a history of COVID-19 and the presence of PCS. The study evaluated laboratory and instrumental tests, and a general clinical study assessing psychocognitive disorders using the SPMSQ and HADS questionnaires was conducted. Results and discussion. In COVID-19 survivors, compared with patients of group 1, there were more pronounced atherogenic changes in total cholesterol (TC) (p=0.003), low-density lipoprotein cholesterol (p<0.001), and triglycerides (p=0.011). Lower dia-stolic blood pressure was found in COVID-19 survivors (p<0.001). In addition, patients in group 2 had higher median pulse pressure (p<0.001) and heart rate (p<0.001). In group 2 patients, a larger ascending aorta diameter was observed (p<0.001). The anx-iety-depressive syndrome was more common in COVID-19 survivors with comorbidities, and a statistically significant difference was found in clinical anxiety (24%, p=0.041) and subclinical depression (21%, p=0.015). When assessing cognitive function, mod-erate cognitive impairment was detected in 22% (p=0.005) of patients with PCS and severe cognitive impairment in 2% (p=0.007). Conclusion. In comorbid elderly patients with the post-COVID syndrome, a high prevalence of psychocognitive disorders and adverse cardiometabolic changes were observed, supporting the need for long-term monitoring of the general clinical condition and psychocognitive status of COVID-19 survivors.Copyright © 2023, Media Sphera Publishing Group. All rights reserved.","PeriodicalId":37659,"journal":{"name":"Profilakticheskaya Meditsina","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67427293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

首页上一页

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Profilakticheskaya Meditsina

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀